Literature DB >> 16636737

[Prescribed and reported drug use during pregnancy].

Claudia Garcia Serpa Osorio-de-Castro1, Vera Lucia Edais Pepe, Vera Lucia Luiza, Marly Aparecida Elias Cosendey, Aline Matias de Freitas, Frederico Fonseca Miranda, Jorge Antonio Zepeda Bermudez, Maria do Carmo Leal.   

Abstract

Few studies describe drug utilization in pregnancy focusing on prescribing practices. This study is part of a larger survey on perinatal care in the City of Rio de Janeiro, Brazil. The type of hospital (public, contracted out by the Unified National Health System, or private) determined the stratification of 10,072 hospitalized post-partum women, who were asked about medication used during pregnancy. Hospital records supplied information on drugs prescribed during labor. Drugs were classified according to the Anatomical Therapeutic Chemical (ATC) system. Another system was used for specific cases of referred use. A mean of 2.08 drugs was prescribed during labor, and a mean of 2.3 was reported during pregnancy. Anesthetics, antibiotics, oxytocin, and analgesics were the most frequently prescribed during labor, with significant differences between strata. Ferrous sulfate, vitamins, scopolamine, and acetaminophen were the main drugs reported during pregnancy. Women who had attempted abortion referred use of various kinds of tea (49.7%) and misoprostol (9.2%). The drug utilization pattern was consistent with the literature. This study offers knowledge on prescribing patterns during labor and self-reported use during pregnancy in both the public and private sectors.

Entities:  

Mesh:

Year:  2004        PMID: 16636737     DOI: 10.1590/s0102-311x2004000700008

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  7 in total

1.  Drug exposure and pregnancy outcome in Mozambique.

Authors:  Esperança Sevene; Azucena Bardají; Alda Mariano; Sónia Machevo; Edgar Ayala; Betuel Sigaúque; John J Aponte; Xavier Carné; Pedro L Alonso; Clara Menendez
Journal:  Paediatr Drugs       Date:  2012-02-01       Impact factor: 3.022

2.  Awareness of Mothers and Doctors about Drug Utilization Pattern for Illnesses Encountered during Pregnancy.

Authors:  Nargis Ibrahim Kureshee; Priti Pravin Dhande
Journal:  J Clin Diagn Res       Date:  2013-11-10

3.  Use of medicines with unknown fetal risk among parturient women from the 2004 Pelotas Birth Cohort (Brazil).

Authors:  Andréa Dâmaso Bertoldi; Tatiane da Silva Dal Pizzol; Aline Lins Camargo; Aluísio J D Barros; Alicia Matijasevich; Iná S Santos
Journal:  J Pregnancy       Date:  2012-12-31

4.  Medication Use among Pregnant Women from the 2015 Pelotas (Brazil) Birth Cohort Study.

Authors:  Bárbara Heather Lutz; Vanessa Iribarrem Avena Miranda; Marysabel Pinto Telis Silveira; Tatiane da Silva Dal Pizzol; Sotero Serrate Mengue; Mariângela Freitas da Silveira; Marlos Rodrigues Domingues; Andréa Dâmaso Bertoldi
Journal:  Int J Environ Res Public Health       Date:  2020-02-05       Impact factor: 4.614

5.  Hypertensive Disorders of Pregnancy and Medication Use in the 2015 Pelotas (Brazil) Birth Cohort Study.

Authors:  Lisiane Freitas Leal; Sonia Marzia Grandi; Vanessa Iribarrem Avena Miranda; Tatiane da Silva Dal Pizzol; Robert William Platt; Mariângela Freitas da Silveira; Andréa Dâmaso Bertoldi
Journal:  Int J Environ Res Public Health       Date:  2020-11-18       Impact factor: 3.390

6.  Quality of antenatal care as a risk factor for early onset neonatal infections in Rio de Janeiro, Brazil.

Authors:  B R Mizumoto; B M Moreira; G Santoro-Lopes; A J Cunha; R M R dos Santos; C L Pessoa-Silva; Azeredo A N Pinheiro; M Ferreira; M B Leobons; Cristina Barroso Hofer
Journal:  Braz J Infect Dis       Date:  2015-03-17       Impact factor: 3.257

7.  Adverse drug reactions in high-risk pregnant women: A prospective study.

Authors:  Alfredo Dias de Oliveira-Filho; Antonio Emanuel Soares Vieira; Roberta Cruz da Silva; Sabrina Joany Felizardo Neves; Thiago Antonio Barros Gama; Ryane Vieira Lima; Wlisses Ramon Oliveira; Júlia Maria de Gonçalves Dias
Journal:  Saudi Pharm J       Date:  2017-02-02       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.